Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Okayama University, 1-1-1 Tsushima-naka, Kita-ku, Okayama, 700-8530, Japan.
Global CMC Regulatory Office, Regulatory Affairs Department, Otsuka Pharmaceutical Co. Ltd., 3-2-27 Otedori Chuo-ku, Osaka, 540-10021, Japan.
Pharm Res. 2022 Sep;39(9):2163-2178. doi: 10.1007/s11095-022-03325-8. Epub 2022 Jul 8.
Serotonin (5-HT) is important for gastrointestinal functions, but its role in drug absorption remains to be clarified. Therefore, the pharmacokinetics and oral absorption of cephalexin (CEX) were examined under 5-HT-excessive condition to understand the role of 5-HT.
5-HT-excessive rats were prepared by multiple intraperitoneal dosing of 5-HT and clorgyline, an inhibitor for 5-HT metabolism, and utilized to examine the pharmacokinetics, absorption behavior and the intestinal permeability for CEX.
Higher levels of 5-HT in brain, plasma and small intestines were recognized in 5-HT-excessive rats, where the oral bioavailability of CEX was significantly enhanced. The intestinal mucosal transport via passive diffusion of CEX was significantly increased, while its transport via PEPT1 was markedly decreased specifically in the jejunal segment, which was supported by the decrease in PEPT1 expression on brush border membrane (BBM) of intestinal epithelial cells. Since no change in antipyrine permeability and significant increase in FITC dextran-4 permeability were observed in 5-HT-excessive rats, the enhanced permeability for CEX would be attributed to the opening of tight junction, which was supported by the significant decrease in transmucosal electrical resistance. In 5-HT-excessive rats, furthermore, total body clearance of CEX tended to be larger and the decrease in PEPT2 expression on BBM in kidneys was suggested to be one of the reasons for it.
5-HT-excessive condition enhanced the oral bioavailability of CEX in rats, which would be attributed to the enhanced permeability across the intestinal mucosa via passive diffusion through the paracellular route even though the transport via PEPT1 was decreased.
5-羟色胺(5-HT)对胃肠道功能很重要,但它在药物吸收中的作用仍需阐明。因此,在 5-HT 过剩的情况下检查了头孢氨苄(CEX)的药代动力学和口服吸收,以了解 5-HT 的作用。
通过多次腹腔注射 5-HT 和氯丙嗪(一种 5-HT 代谢抑制剂)制备 5-HT 过剩大鼠,并利用其检查 CEX 的药代动力学、吸收行为和肠道通透性。
5-HT 过剩大鼠的大脑、血浆和小肠中 5-HT 水平升高,CEX 的口服生物利用度显著提高。CEX 通过被动扩散的肠黏膜转运明显增加,而其通过 PEPT1 的转运则明显减少,特别是在空肠段,这得到了肠上皮细胞刷状缘膜(BBM)上 PEPT1 表达减少的支持。由于在 5-HT 过剩大鼠中未观察到对乙酰氨基酚通透性的变化和 FITC 葡聚糖-4 通透性的显著增加,因此 CEX 的增强通透性归因于紧密连接的开放,这得到了跨黏膜电阻显著降低的支持。此外,在 5-HT 过剩大鼠中,CEX 的全身清除率趋于增大,并且肾脏 BBM 上 PEPT2 表达的减少表明这是原因之一。
5-HT 过剩状态增强了 CEX 在大鼠中的口服生物利用度,这归因于通过细胞旁途径的被动扩散增加了肠道黏膜的通透性,尽管 PEPT1 的转运减少。